When hunting for the best low cost etfs, investors often overlook one of the market’s most compelling options: the Schwab U.S. Large-Cap ETF (NYSE:SCHX). With $32.8 billion in assets under management, this Charles Schwab offering has quietly become a powerhouse for investors seeking broad market exposure without the burden of excessive fees.
Performance That Speaks for Itself
The numbers tell a convincing story. Over the past decade, SCHX has delivered annualized returns of 12.6%, positioning it among the best performers in its category. The five-year annualized return sits at 10.8%, while the three-year figure comes in at 9.9%. These results demonstrate consistent performance across market cycles, making it a reliable core holding for long-term portfolios.
To put this in perspective, SCHX tracks 755 of the largest U.S. companies, giving investors exposure to roughly half the total market capitalization. This breadth of holdings creates the kind of stability that income-focused and growth-oriented investors alike can appreciate.
The Expense Ratio Game-Changer
Here’s where SCHX truly distinguishes itself among low cost etfs: its expense ratio of just 0.03%. This microscopic fee structure represents best-in-class pricing across the ETF landscape. The math is revealing—a $10,000 investment costs merely $3 in annual fees. Over a decade of compound growth at 5% returns, that same investor pays just $39 in total fees while potentially accumulating thousands in wealth.
This cost efficiency becomes even more powerful when compared to higher-fee alternatives. Many broad market funds charge 0.10% or more, which may seem trivial but compounds into meaningful performance drag over time. SCHX’s approach eliminates this hidden wealth drain entirely.
Portfolio Composition: True Diversification, Not Concentration
One critical distinction separates SCHX from many competitors claiming diversification: actual balance. While the fund holds 755 positions, its top 10 holdings comprise only 28.4% of assets. This is diversification with teeth.
The top holdings reflect blue-chip quality: Apple (NASDAQ:AAPL), Microsoft (NASDAQ:MSFT), Amazon (NASDAQ:AMZN), Nvidia (NASDAQ:NVDA), and Alphabet (NASDAQ:GOOG/GOOGL) dominate recent valuations. However, venture beyond these marquee names and you discover genuine sector diversity.
Technology weighs just 28% of holdings, despite dominating headlines. Healthcare contributes 13.3% through stalwarts like UnitedHealth (NYSE:UNH), Eli Lilly (NYSE:LLY), and Johnson & Johnson (NYSE:JNJ). Financials represent 12.7% via Berkshire Hathaway (NYSE:BRK.B), JPMorgan Chase (NYSE:JPM), Visa (NYSE:V), and Mastercard (NYSE:MA).
This balanced approach grants investors exposure to economic diversity—not just tech momentum.
Strategic Framework and Index Methodology
SCHX’s mandate centers on tracking the Dow Jones U.S. Large-Cap Total Stock Market Index, providing investors straightforward access to corporations ranked among the top 750 by full market capitalization. This transparent, rules-based approach eliminates manager discretion and keeps costs predictably low.
By maintaining this mechanical methodology, Charles Schwab ensures that SCHX functions as a true market barometer rather than a performance-chasing vehicle. The result: predictability and consistency that active management rarely delivers.
Wall Street’s Bullish Consensus
Investment analysts assign SCHX a Moderate Buy rating, supported by 606 Buy recommendations, 138 Holds, and 11 Sells accumulated over the past three months. The consensus price target of $61.05 suggests approximately 20.4% upside potential from current levels.
Beyond traditional analyst opinion, TipRanks’ proprietary Smart Score system awards SCHX an 8 out of 10—equivalent to an Outperform rating. This quantitative assessment considers eight major market factors, providing data-driven confidence in the fund’s outlook.
Income Component and Long-Term Growth
SCHX isn’t merely a capital appreciation vehicle. The fund maintains a 1.5% dividend yield, which may seem modest for income hunters but meaningfully contributes to total returns over decades. More importantly, SCHX has maintained consecutive annual dividend payments for 13 years straight, with ample room for growth as underlying companies expand earnings and raise distributions.
Why SCHX Ranks Among Best Low Cost ETFs
For investors comparing options in the low cost etfs space, SCHX checks every important box: minimal fees (0.03%), genuine diversification (755 holdings with balanced top-10 concentration), analyst support, strong historical performance, and blue-chip security exposure. The fund’s negligible expense ratio means more wealth stays in investor pockets rather than flowing to fund operators.
Over time, these seemingly small advantages crystallize into substantial wealth differences. The data confirms what financial science has long demonstrated: low-cost index exposure represents one of the most reliable paths to long-term investment success.
For portfolio builders seeking core holdings with institutional-grade diversification and consumer-friendly pricing, SCHX emerges as a genuinely compelling option worth serious consideration.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Low-Cost ETF Champion: Why SCHX Delivers Outsized Value for Portfolio Growth
When hunting for the best low cost etfs, investors often overlook one of the market’s most compelling options: the Schwab U.S. Large-Cap ETF (NYSE:SCHX). With $32.8 billion in assets under management, this Charles Schwab offering has quietly become a powerhouse for investors seeking broad market exposure without the burden of excessive fees.
Performance That Speaks for Itself
The numbers tell a convincing story. Over the past decade, SCHX has delivered annualized returns of 12.6%, positioning it among the best performers in its category. The five-year annualized return sits at 10.8%, while the three-year figure comes in at 9.9%. These results demonstrate consistent performance across market cycles, making it a reliable core holding for long-term portfolios.
To put this in perspective, SCHX tracks 755 of the largest U.S. companies, giving investors exposure to roughly half the total market capitalization. This breadth of holdings creates the kind of stability that income-focused and growth-oriented investors alike can appreciate.
The Expense Ratio Game-Changer
Here’s where SCHX truly distinguishes itself among low cost etfs: its expense ratio of just 0.03%. This microscopic fee structure represents best-in-class pricing across the ETF landscape. The math is revealing—a $10,000 investment costs merely $3 in annual fees. Over a decade of compound growth at 5% returns, that same investor pays just $39 in total fees while potentially accumulating thousands in wealth.
This cost efficiency becomes even more powerful when compared to higher-fee alternatives. Many broad market funds charge 0.10% or more, which may seem trivial but compounds into meaningful performance drag over time. SCHX’s approach eliminates this hidden wealth drain entirely.
Portfolio Composition: True Diversification, Not Concentration
One critical distinction separates SCHX from many competitors claiming diversification: actual balance. While the fund holds 755 positions, its top 10 holdings comprise only 28.4% of assets. This is diversification with teeth.
The top holdings reflect blue-chip quality: Apple (NASDAQ:AAPL), Microsoft (NASDAQ:MSFT), Amazon (NASDAQ:AMZN), Nvidia (NASDAQ:NVDA), and Alphabet (NASDAQ:GOOG/GOOGL) dominate recent valuations. However, venture beyond these marquee names and you discover genuine sector diversity.
Technology weighs just 28% of holdings, despite dominating headlines. Healthcare contributes 13.3% through stalwarts like UnitedHealth (NYSE:UNH), Eli Lilly (NYSE:LLY), and Johnson & Johnson (NYSE:JNJ). Financials represent 12.7% via Berkshire Hathaway (NYSE:BRK.B), JPMorgan Chase (NYSE:JPM), Visa (NYSE:V), and Mastercard (NYSE:MA).
This balanced approach grants investors exposure to economic diversity—not just tech momentum.
Strategic Framework and Index Methodology
SCHX’s mandate centers on tracking the Dow Jones U.S. Large-Cap Total Stock Market Index, providing investors straightforward access to corporations ranked among the top 750 by full market capitalization. This transparent, rules-based approach eliminates manager discretion and keeps costs predictably low.
By maintaining this mechanical methodology, Charles Schwab ensures that SCHX functions as a true market barometer rather than a performance-chasing vehicle. The result: predictability and consistency that active management rarely delivers.
Wall Street’s Bullish Consensus
Investment analysts assign SCHX a Moderate Buy rating, supported by 606 Buy recommendations, 138 Holds, and 11 Sells accumulated over the past three months. The consensus price target of $61.05 suggests approximately 20.4% upside potential from current levels.
Beyond traditional analyst opinion, TipRanks’ proprietary Smart Score system awards SCHX an 8 out of 10—equivalent to an Outperform rating. This quantitative assessment considers eight major market factors, providing data-driven confidence in the fund’s outlook.
Income Component and Long-Term Growth
SCHX isn’t merely a capital appreciation vehicle. The fund maintains a 1.5% dividend yield, which may seem modest for income hunters but meaningfully contributes to total returns over decades. More importantly, SCHX has maintained consecutive annual dividend payments for 13 years straight, with ample room for growth as underlying companies expand earnings and raise distributions.
Why SCHX Ranks Among Best Low Cost ETFs
For investors comparing options in the low cost etfs space, SCHX checks every important box: minimal fees (0.03%), genuine diversification (755 holdings with balanced top-10 concentration), analyst support, strong historical performance, and blue-chip security exposure. The fund’s negligible expense ratio means more wealth stays in investor pockets rather than flowing to fund operators.
Over time, these seemingly small advantages crystallize into substantial wealth differences. The data confirms what financial science has long demonstrated: low-cost index exposure represents one of the most reliable paths to long-term investment success.
For portfolio builders seeking core holdings with institutional-grade diversification and consumer-friendly pricing, SCHX emerges as a genuinely compelling option worth serious consideration.